Want to join the conversation?
Thompson Research Group analyst Nick Coppola questions $URI on the competitive environment and pricing of fleet growth. COO Matthew Flannery says that it has been competitive for the past 18 months. The company believes that it needs to keep a balanced approach on how it is going to defend the business it has and grow upon new end markets.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?